Trade Report: The Naples Global Advisors LLC Increases Position in UnitedHealth Group Inc. (UNH)

The Naples Global Advisors LLC Increases Position in UnitedHealth Group Inc. (UNH)

Naples Global Advisors LLC raised its stake in shares of UnitedHealth Group Inc. (NYSE:UNH) by 7.0% during the third quarter, Holdings Channel reports. The fund owned 1,942 shares of the healthcare conglomerate’s stock after buying an additional 127 shares during the period. Naples Global Advisors LLC’s holdings in UnitedHealth Group were worth $272,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Hanson McClain Inc. boosted its stake in shares of UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $126,000 after buying an additional 4 shares during the last quarter. Harfst & Associates Inc. boosted its stake in shares of UnitedHealth Group by 0.3% in the second quarter. Harfst & Associates Inc. now owns 2,963 shares of the healthcare conglomerate’s stock valued at $418,000 after buying an additional 8 shares during the last quarter. Kanaly Trust Co boosted its stake in shares of UnitedHealth Group by 0.6% in the second quarter. Kanaly Trust Co now owns 1,772 shares of the healthcare conglomerate’s stock valued at $250,000 after buying an additional 11 shares during the last quarter. Burke & Herbert Bank & Trust Co. boosted its stake in shares of UnitedHealth Group by 0.4% in the third quarter. Burke & Herbert Bank & Trust Co. now owns 2,877 shares of the healthcare conglomerate’s stock valued at $403,000 after buying an additional 12 shares during the last quarter. Finally, First Financial Bank N.A. Trust Division boosted its stake in shares of UnitedHealth Group by 0.3% in the second quarter. First Financial Bank N.A. Trust Division now owns 7,847 shares of the healthcare conglomerate’s stock valued at $1,108,000 after buying an additional 21 shares during the last quarter. Institutional investors and hedge funds own 86.04% of the company’s stock.

Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.48% during mid-day trading on Friday, hitting $152.81. 1,664,542 shares of the stock traded hands. UnitedHealth Group Inc. has a one year low of $107.51 and a one year high of $154.50. The company has a market cap of $145.45 billion, a P/E ratio of 22.57 and a beta of 0.63. The stock has a 50 day moving average price of $143.37 and a 200-day moving average price of $139.61.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.09. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The firm earned $46.30 billion during the quarter, compared to the consensus estimate of $46.09 billion. During the same quarter in the previous year, the company posted $1.77 EPS. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. On average, analysts forecast that UnitedHealth Group Inc. will post $8.01 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 13th. Investors of record on Friday, December 2nd will be paid a $0.625 dividend. This represents a $2.50 annualized dividend and a yield of 1.64%. The ex-dividend date is Wednesday, November 30th. UnitedHealth Group’s payout ratio is 36.93%.

Several research firms recently issued reports on UNH. Leerink Swann reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday. Credit Suisse Group AG reiterated an “outperform” rating and issued a $160.00 target price (up from $155.00) on shares of UnitedHealth Group in a research note on Friday, October 21st. Mizuho boosted their target price on shares of UnitedHealth Group from $160.00 to $169.00 and gave the company a “buy” rating in a research note on Wednesday, October 19th. Vetr cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $144.66 target price for the company. in a research note on Tuesday, October 18th. Finally, Jefferies Group reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Tuesday, August 23rd. Two research analysts have rated the stock with a hold rating and twenty-two have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $158.03.

In related news, Director Richard T. Burke sold 40,000 shares of the business’s stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kenneth Irwin Shine sold 325 shares of the business’s stock in a transaction dated Friday, October 21st. The shares were sold at an average price of $144.99, for a total transaction of $47,121.75. Following the completion of the transaction, the director now directly owns 28,613 shares of the company’s stock, valued at approximately $4,148,598.87. The disclosure for this sale can be found here. 1.65% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Related posts

Leave a Comment